How does 6999's PB Ratio compare to its peers?

Insufficient data to calculate 6999's Price-To-Book Ratio vs. peers for valuation analysis.

How does 6999's PB Ratio compare vs other companies in the TW Biotechs Industry?

Insufficient data to calculate 6999's Price-To-Book Ratio vs. industry for valuation analysis.

What is 6999's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate 6999's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of 6999 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate 6999's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Han.biomedical (TPEX:6999) - Stock Price, News & Analysis

6999 Stock Overview

Develops structured biomaterials for tissue regeneration in Taiwan. More details

6999 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (NT$682M)

Volatile share price over the past 3 months compared to the TW market

Han.biomedical Inc. Competitors

Vectorite Biomedical

TPEX:4170

NT$656.6m

Pharmigene

TPEX:7595

NT$721.6m

TaiwanJ Pharmaceuticals

TPEX:6549

NT$710.7m

Bioray Biotech

TPEX:7561

NT$619.0m

Price History & Performance

Summary of all time highs, changes and price drops for Han.biomedical
Historical stock prices
Current Share Price	NT$35.95
52 Week High	NT$45.34
52 Week Low	NT$33.41
Beta	0
11 Month Change	-1.37%
3 Month Change	-20.71%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-13.42%

Recent updates

Shareholder Returns

	6999	TW Biotechs	TW Market
7D	-0.8%	-2.2%	-1.2%
1Y	n/a	-2.8%	25.7%

Return vs Industry: Insufficient data to determine how 6999 performed against the TW Biotechs industry.

Return vs Market: Insufficient data to determine how 6999 performed against the TW Market.

Price Volatility

Is 6999's price volatile compared to industry and market?
6999 volatility
6999 Average Weekly Movement	7.3%
Biotechs Industry Average Movement	4.1%
Market Average Movement	4.6%
10% most volatile stocks in TW Market	8.0%
10% least volatile stocks in TW Market	2.2%

Stable Share Price: 6999's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: Insufficient data to determine 6999's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	www.hanbiomedical.com

Han biomedical Inc. develops structured biomaterials for tissue regeneration in Taiwan. It offers BarriGel adhesion prevention gel; HANBIO patient lubricant; HANCARE collagen matrix; HANBIO gauze; and LEOFOR hyaluronic acid solution.

Han.biomedical Inc. Fundamentals Summary

How do Han.biomedical's earnings and revenue compare to its market cap?
6999 fundamental statistics
Market cap	NT$682.28m
Earnings (TTM)	NT$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 6999 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6999 income statement (TTM)
Revenue	NT$0
Cost of Revenue	NT$0
Gross Profit	NT$0
Other Expenses	NT$0
Earnings	NT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 6999 perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

n/a

Payout Ratio

Han.biomedical TPEX:6999 Stock Report